| Soyoung Park, MD | |
|
10460 N 92nd St Ste 300, Scottsdale, AZ 85258-4547 | |
| (480) 323-1573 | |
| (480) 323-1375 |
| Full Name | Soyoung Park |
|---|---|
| Gender | Female |
| Speciality | Medical Oncology |
| Experience | 12 Years |
| Location | 10460 N 92nd St Ste 300, Scottsdale, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013279256 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Western Regional Medical Center | Goodyear, AZ | Hospital |
| Wickenburg Community Hospital | Wickenburg, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ctca Physicians Group Of Arizona Llc | 2264593474 | 100 |
News Archive
According to the latest U.S. government survey on chemical exposures, levels of lead have dropped dramatically, exposure to second-hand smoke is down and most women are not carrying unsafe levels of mercury.
The traditional practice of restricting food and fluids during labour does not provide any benefits, finds a new review co-authored by a Queen's University Associate Professor.
Clavis Pharma ASA announces that positive clinical data from its Phase II study with its lead cancer product candidate elacytarabine in patients with late-stage acute myeloid leukaemia (AML) was presented at the 51st American Society of Hematology (ASH) Annual Meeting in New Orleans, LA, USA.
Researchers at the University of Pittsburgh and their collaborators have been awarded a $5.6 million federal contract to pursue the continued development of an implanted ventricular assist heart pump for infants and small children with congenital or acquired heart disease. The project aims to provide much-needed access to the sophisticated technologies that have saved the lives of older heart failure patients.
Research has shown that the tumor microenvironment (TME) can help cancers grow and evade the immune response. The TME has even been shown to inhibit cellular immunotherapy, a novel form of treatment in which the cells of a patient's immune system are re-engineered in the lab to attack cancer cells.
› Verified 7 days ago
| Entity Name | Honorhealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801092564 PECOS PAC ID: 1456258607 Enrollment ID: O20031216000350 |
News Archive
According to the latest U.S. government survey on chemical exposures, levels of lead have dropped dramatically, exposure to second-hand smoke is down and most women are not carrying unsafe levels of mercury.
The traditional practice of restricting food and fluids during labour does not provide any benefits, finds a new review co-authored by a Queen's University Associate Professor.
Clavis Pharma ASA announces that positive clinical data from its Phase II study with its lead cancer product candidate elacytarabine in patients with late-stage acute myeloid leukaemia (AML) was presented at the 51st American Society of Hematology (ASH) Annual Meeting in New Orleans, LA, USA.
Researchers at the University of Pittsburgh and their collaborators have been awarded a $5.6 million federal contract to pursue the continued development of an implanted ventricular assist heart pump for infants and small children with congenital or acquired heart disease. The project aims to provide much-needed access to the sophisticated technologies that have saved the lives of older heart failure patients.
Research has shown that the tumor microenvironment (TME) can help cancers grow and evade the immune response. The TME has even been shown to inhibit cellular immunotherapy, a novel form of treatment in which the cells of a patient's immune system are re-engineered in the lab to attack cancer cells.
› Verified 7 days ago
| Entity Name | Sjhmc Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326098005 PECOS PAC ID: 4486646197 Enrollment ID: O20040401001189 |
News Archive
According to the latest U.S. government survey on chemical exposures, levels of lead have dropped dramatically, exposure to second-hand smoke is down and most women are not carrying unsafe levels of mercury.
The traditional practice of restricting food and fluids during labour does not provide any benefits, finds a new review co-authored by a Queen's University Associate Professor.
Clavis Pharma ASA announces that positive clinical data from its Phase II study with its lead cancer product candidate elacytarabine in patients with late-stage acute myeloid leukaemia (AML) was presented at the 51st American Society of Hematology (ASH) Annual Meeting in New Orleans, LA, USA.
Researchers at the University of Pittsburgh and their collaborators have been awarded a $5.6 million federal contract to pursue the continued development of an implanted ventricular assist heart pump for infants and small children with congenital or acquired heart disease. The project aims to provide much-needed access to the sophisticated technologies that have saved the lives of older heart failure patients.
Research has shown that the tumor microenvironment (TME) can help cancers grow and evade the immune response. The TME has even been shown to inhibit cellular immunotherapy, a novel form of treatment in which the cells of a patient's immune system are re-engineered in the lab to attack cancer cells.
› Verified 7 days ago
| Entity Name | Ctca Physicians Group Of Arizona Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609026806 PECOS PAC ID: 2264593474 Enrollment ID: O20081205000793 |
News Archive
According to the latest U.S. government survey on chemical exposures, levels of lead have dropped dramatically, exposure to second-hand smoke is down and most women are not carrying unsafe levels of mercury.
The traditional practice of restricting food and fluids during labour does not provide any benefits, finds a new review co-authored by a Queen's University Associate Professor.
Clavis Pharma ASA announces that positive clinical data from its Phase II study with its lead cancer product candidate elacytarabine in patients with late-stage acute myeloid leukaemia (AML) was presented at the 51st American Society of Hematology (ASH) Annual Meeting in New Orleans, LA, USA.
Researchers at the University of Pittsburgh and their collaborators have been awarded a $5.6 million federal contract to pursue the continued development of an implanted ventricular assist heart pump for infants and small children with congenital or acquired heart disease. The project aims to provide much-needed access to the sophisticated technologies that have saved the lives of older heart failure patients.
Research has shown that the tumor microenvironment (TME) can help cancers grow and evade the immune response. The TME has even been shown to inhibit cellular immunotherapy, a novel form of treatment in which the cells of a patient's immune system are re-engineered in the lab to attack cancer cells.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Soyoung Park, MD 1760 E River Rd Ste 350, Tucson, AZ 85718-5999 Ph: (520) 519-7775 | Soyoung Park, MD 10460 N 92nd St Ste 300, Scottsdale, AZ 85258-4547 Ph: (480) 323-1573 |
News Archive
According to the latest U.S. government survey on chemical exposures, levels of lead have dropped dramatically, exposure to second-hand smoke is down and most women are not carrying unsafe levels of mercury.
The traditional practice of restricting food and fluids during labour does not provide any benefits, finds a new review co-authored by a Queen's University Associate Professor.
Clavis Pharma ASA announces that positive clinical data from its Phase II study with its lead cancer product candidate elacytarabine in patients with late-stage acute myeloid leukaemia (AML) was presented at the 51st American Society of Hematology (ASH) Annual Meeting in New Orleans, LA, USA.
Researchers at the University of Pittsburgh and their collaborators have been awarded a $5.6 million federal contract to pursue the continued development of an implanted ventricular assist heart pump for infants and small children with congenital or acquired heart disease. The project aims to provide much-needed access to the sophisticated technologies that have saved the lives of older heart failure patients.
Research has shown that the tumor microenvironment (TME) can help cancers grow and evade the immune response. The TME has even been shown to inhibit cellular immunotherapy, a novel form of treatment in which the cells of a patient's immune system are re-engineered in the lab to attack cancer cells.
› Verified 7 days ago
Russell S Ruzich, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 13400 E Shea Blvd, Scottsdale, AZ 85259 Phone: 480-301-8000 | |
Dr. Paul Joseph Schenk, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 11230 E Beck Ln, Scottsdale, AZ 85255 Phone: 480-502-9457 | |
Dr. Musab Sultan Hommos, M.B., B.S. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 13400 E Shea Blvd, Scottsdale, AZ 85259 Phone: 480-301-8000 | |
Dr. Michael Edward Killian, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: Mayo Clinic 13400 E Shea Blvd, Scottsdale, AZ 85259 Phone: 085-120-6856 | |
Hesham Mubarak Ibrahim Moh Abdalla, M.B.B.S. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 13400 E Shea Blvd, Scottsdale, AZ 85259 Phone: 480-301-8000 | |
Kianoush Cheybani, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 9590 E Ironwood Square Dr, Ste 125, Scottsdale, AZ 85258 Phone: 480-455-3000 Fax: 866-819-6115 |